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Background: Nuclear myosin 1c (NM1) is emerging as a regulator of transcription and chromatin organization.
Results: Using chromatin immunoprecipitation and deep sequencing (ChIP-Seq) in combination with molecular
analyses, we investigated the global association of NM1 with the mammalian genome. Analysis of the ChIP-Seq
data demonstrates that NM1 binds across the entire mammalian genome with occupancy peaks correlating with
distributions of RNA Polymerase II (Pol II) and active epigenetic marks at class II gene promoters. In mouse embryonic
fibroblasts subjected to RNAi mediated NM1 gene silencing, we show that NM1 synergizes with polymerase-associated
actin to maintain active Pol II at the promoter. NM1 also co-localizes with the nucleosome remodeler SNF2h at class II
promoters where they assemble together with WSTF as part of the B-WICH complex. A high resolution micrococcal
nuclease (MNase) assay and quantitative real time PCR shows that this mechanism is required for local chromatin
remodeling. Following B-WICH assembly, NM1 mediates physical recruitment of the histone acetyl transferase PCAF
and the histone methyl transferase Set1/Ash2 to maintain and preserve H3K9acetylation and H3K4trimethylation for
active transcription.
Conclusions: We propose a novel genome-wide mechanism where myosin synergizes with Pol II-associated actin to
link the polymerase machinery with permissive chromatin for transcription activation.
Keywords: RNA polymerase II transcription, NM1, Epigenetics, Genome-wide analysisBackground
Gene expression programs are activated and repressed
via ATP-dependent chromatin remodeling and epigenetic
modifications. During spatial and temporal activation of
genes these mechanisms target nucleosomes, DNA and
histone tails [1, 2], impacting both cellular function and
organismal development. By repositioning nucleosomes,
ATP-dependent chromatin remodelers contribute to chro-
matin accessibility and exposure of DNA regulatory ele-
ments [3]. At the gene promoter, these mechanisms must
be coordinated with a range of histone modifications, in-
cluding acetylation, methylation, phosphorylation and ubi-
quitination, to collectively define different gene activity
states [4, 5]. Acetylation on K9 of histone H3 (H3K9ac) by
histone acetyl transferases (HAT) is commonly found at* Correspondence: piergiorgio.percipalle@ki.se
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genetic mark for active transcription. Although there are
examples of enrichment at other genomic regions [6, 7],
H3K4 trimethylation (H3K4me3) by histone methyl trans-
ferases (HMTs) is also associated with active chromatin,
enriched at both active and poised promoters [8]. One
critical histone mark that cooperates with H3K4me3 at
active promoters is the modification of H3K27 by acetyl-
ation (H3K27ac) [9]. H3K27ac together with the mono-
methyl state of H3K4 (H3K4me1) also marks active gene
enhancers [10–12]. Although both remodeling and his-
tone modifications are essential to open up the chromatin
and, thus, regulate accessibility of RNA polymerase to be-
come engaged in active transcription, how recruitment of
remodelers and active epigenetic marks is temporally or-
chestrated and preserved is not fully understood.
Motor proteins such as myosin are emerging as key
regulators of chromatin. They coordinate global chroma-
tin dynamics with gene-specific activities and directlyss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Among the nuclear myosin species, the myosin 1c iso-
form B - referred to as nuclear myosin 1 (NM1) - is the
best characterized both in terms of location and function
[14–21]. NM1 works with actin and nuclear components
to regulate different steps in the gene expression path-
way [13, 22, 23] and has an impact at the genomic level
[21]. NM1 associates with the chromatin and this associ-
ation is functional since NM1 localizes to both nuclear
and nucleolar transcription sites in an RNA-dependent
manner [15, 19, 24–26]. At the rRNA gene promoter,
the interaction between the chromatin-bound NM1 and
the RNA polymerase I (Pol I)-associated actin is re-
quired for transcription activation [25]. NM1 is also part
of B-WICH, a multiprotein assembly that contains the
WICH chromatin remodeling complex with the subunits
WSTF and the ATPase SNF2h [19, 27, 28]. On the
rDNA we found that WSTF bookmarks the position of
the chromatin remodeling complex while NM1 interacts
with SNF2h to stabilize B-WICH, leading to recruitment
of the HAT PCAF for H3K9 acetylation [25]. NM1 has
therefore been proposed to connect Pol I with the rDNA
through direct interactions with the Pol I-associated
actin and chromatin, respectively. Since this mechanism
depends on the myosin ATPase activity and the catalytic
activity of NM1 is required for Pol I transcription, NM1
is likely to function as an actin-based motor that acti-
vates transcription by providing a permissive chromatin
state for rapid Pol I transcription activation [20, 25, 26].
Actin also interacts with unphosphorylated RNA poly-
merase II (Pol II) as well as hypo- (phospho-S5) and
hyperphosphorylated (phospho-S5 and phospho-S2)
forms of Pol II [29–31]. There is also in vitro evidence
that NM1 plays a role in Pol II transcription at different
stages [13, 14, 18]. Whether the chromatin-based mech-
anisms described above generally apply to Pol II is, how-
ever, not known.
We set out to investigate whether NM1 has a funda-
mental function at class II promoters, contributing to
the maintenance of a chromatin state required for Pol II
transcription activation. Using chromatin immunopre-
cipitation and deep sequencing (ChIP-Seq), we show, for
the first time, association of a myosin species with a
mammalian genome. The results from pairwise compari-
sons of the genomic distributions of NM1 and SNF2h
[3] show co-localization at multiple genomic locations.
Within a subset of these locations NM1, SNF2h and
WSTF are enriched at active class II promoters where
NM1 specifically maintains hypophosphorylated Pol II
levels and modulates B-WICH assembly, including
SNF2h recruitment for local chromatin remodeling. We
demonstrate that this, in turn, leads to recruitment of
the HAT PCAF and the HMT Set1/Ash2, for H3K9
acetylation and H3K4 trimethylation, respectively. Wepropose that at class II promoters NM1 activates tran-
scription through a chromatin-based mechanism that
coordinates recruitment of chromatin remodelers and
preserves active epigenetic marks.
Results
Measuring NM1 occupancy across the mammalian
genome
To study the distribution of NM1 across the mammalian
genome, we performed chromatin immunoprecipitation
and deep sequencing (ChIP-Seq) analysis using a previ-
ously characterized affinity-purified antibody specific for
NM1 [15]. Briefly, after in vivo crosslinking with formal-
dehyde, chromatin was isolated from mouse embryonic
fibroblasts (MEFs) and subjected to immunoprecipita-
tion with the anti-NM1 antibody. The captured DNA
was released by reversing the cross-linking, and the
resulting DNA library was sequenced using the Illumina
HiSeq 2000 platform. We identified a total of 25,738,820
reads which were then aligned against the mouse gen-
ome to map specific regions enriched for NM1. The
results show that the majority of unique reads were
mapped to intergenic regions, introns and promoters,
including the transcription start site (TSS) and to a
lesser degree, to exons and untranslated regions
(Fig. 1a-c).
The significance of NM1 association with intergenic
sequences remains to be understood. Functional cluster-
ing of peak-related genes via Gene Ontology revealed,
however, that NM1 is associated with Pol II genes in-
volved in a wide range of biological, cellular and mo-
lecular functions (Additional file 1: Figure S1; Additional
file 2: Table S1). Analysis of selected ChIP-Seq profiles
validated by independent ChIP/qPCR experiments
showed peaks of NM1 occupancy at promoters and
across the gene, at both intronic and exonic sequences
(Fig. 2; Additional file 3: Figure S2; Additional file 4:
Figure S3). To further characterize the localization of
NM1 at the gene level, we interrogated the mouse gen-
ome to find out whether NM1 occupancy at class II
promoters is compatible with the distributions of Pol II
or epigenetic marks for active transcription. Using the
tools available in the University of California Santa
Cruz (UCSC) genome browser we analyzed several
promoters such as the checkpoint clamp complex pro-
tein Rad9 gene (Rad9a), selected as NM1 binders from
our ChIP-Seq analysis. We found that NM1 showed
similar patterns of occupancy as Pol II, H3K4me3,
H3k9ac and H3k27ac. In particular, at the gene pro-
moter and around the transcription start site, the NM1
occupancy peaks co-localized with those of Pol II,
H3K9ac, H3K27ac and H3K4me3 but did not correlate
with the distribution of the epigenetic mark for active
enhancers H3K4me1 (Fig. 3a and b).
Fig. 1 (See legend on next page.)
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Fig. 1 Genome wide analysis by ChIP-Seq shows that NM1 binds across the mouse genome. a Pie chart representation of ChIP-Seq analysis with
the anti NM1 antibody showing preferred NM1 occupancies. Within genic regions NM1 is enriched at class II promoters as well as intronic and
exonic sequences. b-c NM1 occupancy at class II promoters concentrates around the transcription start site (TSS), in a region comprised
between −500 bp and 500 bp from TSS bp base pair, ChIP-Seq chromatin immunoprecipitation and deep sequencing, NM1 nuclear myosin 1c
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ulates Pol II transcription and may do so through a
chromatin-based mechanism that leads to correct depos-
ition of the epigenetic marks H3K4me3, H3k9ac and
H3k27ac.
Transcription activation at class II promoters requires NM1
We next evaluated whether and how NM1 may be in-
volved in transcription regulation of class II promoters.
For this, we silenced NM1 by RNAi (Fig. 4a-b). Lysates
prepared from NM1-silenced cells or cells treated with
control scrambled RNAi (scrRNAi) oligonucleotides
were analyzed on immunoblots with anti-NM1 and anti-
actin antibodies (Fig. 4a). As control against possible off-
target effects in our RNAi-mediated NM1 silencing, the
same membranes probed for NM1 and subsequently for
actin were stripped and re-probed with an anti-pan-
myosin 1C antibody against an epitope present in the
tail of all three myosin 1C isoforms (Fig. 4b) (reviewed
in [13]). We next isolated poly A mRNA from MEFs
subjected to RNAi-mediated NM1 gene silencing and
measured relative mRNA levels from several genes, se-
lected from the NM1 ChIP-Seq results. For the analysis,
we selected eight different mouse protein-coding genes
covering different cellular functions. We included mouse
genes encoding ribosomal proteins (Rplp0, Rpl13a, Rpl19),
transcription factors (Junb), Rad9a, the pre-mRNA-
splicing regulator Wtap (Wilms tumor 1-associating pro-
tein), RNA helicases (Ddx46) as well as apoptotic factors
such as the BCL2-associated agonist of cell death (Bad).
Results from the reverse transcription real time PCR (RT-
qPCR) analysis show that NM1 gene silencing specifically
induced a reduction in the relative levels of transcripts
(Fig. 4c). Consistent with in vitro evidence that NM1 asso-
ciates with Pol II [14], the above results suggest a possible
role for NM1 in transcriptional regulation.
We next asked whether NM1 performs a potential
regulatory function by facilitating Pol II association with
the gene promoter. For this, we applied ChIP to cross-
linked chromatin from MEFs subjected to NM1 gene si-
lencing, using antibodies against unphosphorylated and
hypophosphorylated Pol II. We also used antibodies
against actin and the actin-binding core subunits Rpb6
(RPABC2) and Rpb8 (RPABC3) common to all nuclear
RNA polymerases [32, 33] which are also known to
directly interact with the largest Pol II subunit. The re-
sults from the qPCR analyses with primers amplifying
the promoters of the mouse Rad9a and Rpl19 genes(selected from the NM1 ChIP Seq analysis among the
NM1 top binders) revealed drops in the levels of hypo-
phosphorylated Pol II, actin, Rpb6 and Rpb8 as a conse-
quence of NM1 gene silencing whereas the levels of
unphosphorylated Pol II did not significantly change
(Fig. 4 d-g).
Since phosphorylation of the Pol II CTD occurs during
transcription activation and marks Pol II engagement in
the transcriptional process, the above results altogether
suggest that NM1 may specifically activate transcription
by maintaining Pol II in complex with actin at the gene
promoter.
NM1 regulates chromatin changes compatible with Pol II
transcription activation
We next asked whether the positive regulatory effect of
NM1 on Pol II association with the gene promoter oc-
curs through a chromatin-based mechanism. Since NM1
is part of the B-WICH complex [19], we began address-
ing the above question by comparing the genomic distri-
butions of NM1 and SNF2h. A recent work mapped the
different locations of SNF2h across the mouse genome
[3]. Pairwise comparisons of the genomic sites occupied
by NM1 and SNF2h showed that they co-localize within
a considerable number of genes (Fig. 5a; Additional file 5:
Table S2). Among these genes we selected some pro-
moters and studied whether in the absence of NM1, occu-
pancies of SNF2h as well as WSTF are altered. For this,
we applied ChIP to in vivo crosslinked chromatin from
NM1-silenced MEFs using antibodies to WSTF and
SNF2h. The results from the qPCR analysis on the precip-
itated DNA show that SNF2h occupancy levels dropped
across all promoters tested whereas the levels of WSTF
fluctuated in a gene specific manner (Fig. 5b-c; Additional
file 6: Figure S4A-D).
These results suggest that at those gene promoters
where NM1 regulates association of both SNF2h and
WSTF, NM1 may have an impact on the local structure
of chromatin. We therefore began to look for NM1-
dependent changes in chromatin accessibility by apply-
ing a high resolution micrococcal nuclease (MNase)
assay [25, 34] on chromatin isolated from NM1 silenced
MEFs. The results from the qPCR analyses with primers
amplifying regions upstream and downstream the tran-
scription start site (−250 kb to +100 kb) of the Rpl19
gene promoter show that knocking down the NM1 gene
induced only marginal chromatin protection over the
Rpl19 gene promoter at position −70 (Fig. 5d), as revealed
Fig. 2 ChIP-Seq profiles showing occupancies of NM1 at selected class II genes. The profiles show peaks of NM1 occupancy at the promoters of
mouse genes encoding ribosomal proteins (Rplp0, Rpl13a, RPLP19), the transcription factor Junb, Rad9a and the Holliday junction recognition
protein (Hjurp) ChIP-Seq chromatin immunoprecipitation and deep sequencing, NM1 nuclear myosin 1c
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Fig. 3 ChIP-Seq profile of the mouse Rad9a gene corresponding to the promoter region. (a) The ChIP-Seq profile for NM1 aligned against the
mouse genome from (a) MEFs and (b) from the mouse heart correlate with the ChIP-Seq profiles for Pol II, H3K4ac, H3K27ac, H3K9ac, the HAT
P300, H3K4me3 but does not correlate with H3K4me1. In the comparative analysis both MEFs and tissue (heart) were used to be able to include
the H3K9ac ChIP-seq data. The tissue data used for this comparison were obtained from the UCSC browser. Importantly, in all cases the data sets
were aligned against the same mouse genome (mm9) and they are therefore comparable ChIP-Seq chromatin immunoprecipitation and deep
sequencing, MEFs mouse embryonic fibroblasts, NM1 nuclear myosin 1c, UCSC University of California Santa Cruz
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extent of chromatin protection was significantly enhanced
when we performed MNase digestions on chromatin iso-
lated from HEK293T cells stably expressing mutated NM1
constructs that function as dominant negatives in tran-
scription [20, 25] (see also Fig. 5h). Specifically, we used
HEK293T cells expressing wild-type V5-tagged NM1
(V5-wt NM1), a mutated NM1 variant that cannot bind
to actin (V5-RK605AA NM1) but avidly interacts with
SNF2h [25] while displaying decreased chromatin bind-
ing ability (Additional file 7: Figure S5) or a deletion
construct lacking the C-terminus (V5-ΔC NM1) which
cannot interact with the chromatin (Fig. 5e; Additional
file 7: Figure S5; see also ref. [25]). The results from the
qPCR analyses with primers amplifying regions up-
stream and downstream the transcription start site(−350 kb to +100 kb) of the human RPL19 gene
promoter show that expression of either V5-wtNM1 or
V5-ΔC NM1 did not generally affect chromatin accessibil-
ity (Fig. 5f). In contrast, stable expression of V5-RK605AA
NM1 produced a significant closing of the chromatin at
position −70 kb similar to the NM1 knockdown situation
but considerably enhanced (Fig. 5f). The same experiment
also revealed the significant establishment of a hyper-
sensitive site further upstream at position −140 (Fig. 5f ).
We next performed ChIP on chromatin isolated from
HEK293T cells expressing V5-wtNM1 or V5-RK605AA
NM1 with antibodies to actin, WSTF and SNF2h as well
as a control antibody. The results from the qPCR ana-
lysis with primers amplifying the same region around
position −70 within the human RPL19 gene promoter
show that expression of RK605AA NM1 induced a drop
Fig. 4 (See legend on next page.)
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Fig. 4 NM1 is required for the activation of Pol II transcription. a Steady state expression levels for NM1 and actin were analyzed on immunoblots
of lysates prepared from control (scrRNAi) and NM1-silenced MEFs with an antibody to NM1 and with an antibody against actin. Right panel,
densitometric analysis of the immunoblots for semi-quantitative measurements of NM1 steady state protein expression relative to actin. b Immunoblots
on lysates from control (scrRNAi) and NM1-silenced MEFs with an antibody to NM1, an anti-pan-myosin 1C antibody against an epitope present in the
tail of all three myosin 1C isoforms and with an antibody against actin show marginal off-target effects in the NM1 gene silencing experiment by RNAi.
c RT-qPCR analysis of mRNA transcripts on polyA mRNA prepared from MEFs subjected to NM1 gene knockdown (NM1 RNAi) or from MEFs subjected
to control siRNA oligonucleotides (scrRNAi). The mRNA levels are relative to β-actin mRNA. Error bars represent the standard deviation of
three independent experiments (n = 3). d-g NM1 is required for promoter association of the active Pol II and actin. ChIP and qPCR analysis
on chromatin isolated from NM1 knockdown cells (NM1 RNAi) and control cells (scrRNAi), using antibody against NM1, active (4H8) and
inactive (8WG16) Pol II, actin, Rpb6 and Rpb8. In all cases, qPCR analysis was performed with primers amplifying (d, f) the mouse Rad9a gene
promoter and (e, g) the mouse Rpl19 gene promoter. The values from the qPCR analyses are presented as the percentage of the input signal
for each primer pair. All ChIP experiments were successfully repeated three times (n= 3). Error bars represent standard deviations. In panel D, pPol II(4H8) =
0.02 (*); in panel E, pPol II(4H8) = 0.015 (*); in panel F, pactin = 0.05 (*), pRpb6 = 0.025 (*); in panel G, pactin = 0.000522 (***), pRpb6 = 0.0010 (***), pRpb8 = 0.01 (**).
Significances were obtained by Student’s t-test, two-sample equal variance. ns = non-significant. In the cartoons above the bars diagrams, arrows point to
the approximate position of primers amplifying 150 bp within the promoters bp base pair, ChIP-Seq chromatin immunoprecipitation and deep
sequencing, MEFs mouse embryonic fibroblasts, NM1 nuclear myosin 1c, qPCR quantitative polymerase chain reaction
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results demonstrate the requirement for a fully func-
tional NM1 for actin association with the promoter (see
also Fig. 4d and e). Moreover, these results suggest that
the decreased levels of SNF2h upon stable RK605AA
NM1 expression are due to SNF2h sequestration that
negatively regulates chromatin, since the RK605AA
NM1 mutant interacts with SNF2h and displays
decreased chromatin binding efficiency. If NM1 is im-
portant for Pol II transcription activation and affects oc-
cupancies of actin and SNF2h, Pol II transcription levels
should drop in the cells that stably express NM1 mu-
tants that cannot interact with actin or with chromatin.
Indeed, RT-qPCR analysis of the relative RAD9A and
RPL19 mRNA levels on total polyA mRNA isolated
from HEK293T cells stably expressing V5-RK605AA
NM1 and V5-ΔC NM1 shows significant drops in Pol II
transcription in comparison to wild-type (Fig. 5h;
Additional file 7: Figure S5). Further, ChIP and qPCR
analysis on chromatin isolated from HEK293T cells
expressing V5-wtNM1, V5-RK605AA NM1 or V5-ΔC
NM1 with antibodies to actin, hypophosphorylated Pol
II CTD as well as control antibodies to non-specific
IgGs show that expression of RK605AA NM1 and V5-
ΔC NM1 induced drops in the levels of actin and Pol II
at the promoters of the RAD9A, RPL19 genes (Fig. 5i).
These findings confirm that NM1 plays a primary role
in Pol II transcription and further support that NM1 ac-
tivates transcription by maintaining Pol II in complex
with actin at the gene promoter.
We next tested whether NM1 mediates recruitment of
histone modifiers. The involvement of NM1 in the regu-
lation of H3 acetylation and methylation became plaus-
ible when we found a correlation of the NM1 peaks of
occupancy with promoter-specific acetylation and tri-
methylation of histone H3 (Fig. 3). Furthermore, PCAF
and the HMT Set1/Ash2 that respectively target H3 for
acetylation and trimethylation are both part of the samecomplex with NM1 [25, 26]. To find out whether at class
II promoters these interactions are functional, we si-
lenced NM1 and applied ChIP using antibodies against
PCAF and Set1/Ash2. The results from the qPCR ana-
lysis show that in the absence of NM1 the occupancy
levels of both histone modifiers significantly dropped at
all class II promoters tested, including the promoters of
mouse Rpl19 and Rad9a genes (Fig. 6a and b). Import-
antly, at both promoters the NM1-dependent reductions
in PCAF and Set1/Ash2 occupancy levels were accom-
panied by significant reductions in the levels of H3K9ac,
H3K4me3 and H3K27ac, but not in the case of H3K4m1
(Fig. 6c and d). At class II promoters NM1 is, therefore,
important for recruitment of both HATs and HMTs that
will, in turn, acetylate and trimethylate H3 to generate
active epigenetic marks.
We conclude that a functional NM1 is required to
regulate recruitment of the chromatin remodeler SNF2h
and histone modifiers in order to ensure an active chro-
matin state which is compatible with Pol II transcription.
Discussion
We describe, for the first time, the functional association
of a myosin motor, NM1, with a mammalian genome.
ChIP-Seq analysis demonstrates that NM1 binds to both
non-coding and coding regions of the mouse genome.
When partitioning the coding sequences into promoter,
exons, introns and UTRs, we found that NM1 is particu-
larly enriched at class II promoters, compatible with a
role for NM1 in the initial phases of Pol II transcription.
At the gene level, NM1 has been coupled to the co-
ordination of pre-initiation complex (PIC) assembly and
in transcription activation when Pol II becomes fully
phosphorylated and the transcription machinery is
cleared from the promoter [13]. We show evidence that
NM1 gene silencing marginally affected occupancy of
unphosphorylated Pol II but impaired promoter associ-
ation of hypophosphorylated Pol II; this suggests that
Fig. 5 NM1 controls the levels of SNF2h at class II promoters but it is not required for chromatin remodeling. NM1 C-terminus and intact motor function are
required for the association of Pol II with promoters of class II genes. a Venn diagrams displaying overlap of occupancy between NM1 and SNF2h across
genic regions. b, c ChIP and qPCR analysis on chromatin isolated from NM1 knockdown cells (NM1 RNAi) and control cells (scrRNAi), using antibodies against
WSTF, SNF2h and NM1. The qPCR analysis was performed with primers amplifying the gene promoters of (b) the mouse checkpoint clamp complex protein
Rad9a gene (Rad9a), (c) the mouse ribosomal protein gene Rpl19. In all cases, the values are presented as the percentage of the input signal for each primer
pair. All ChIP experiments were performed at least three time (n= 3). Error bars represent standard deviations. Significances (p-values) were obtained by
Student’s t-test, two-sample equal variance. Panel B, pWSTF = 0.042 (*), pSNF2h = 0.0036 (**); panel C, pWSTF = 0.001 (**), pSNF2h = 0.017 (*). ns = non-significant.
d Chromatin profile from HEK293T cells subjected to control (scrRNAi) or to NM1 gene silencing (NM1 RNAi) shown as 2ΔCt of undigested and MNase
digested cross-linked chromatin. Similar to panel H, the position of each primer pair within the human RPL19 gene is indicated below the graph. The
location +100 bp corresponds to the coding region of the gene; the location +1 bp corresponds to the transcription start site; the location −70 bp
corresponds to a sequence upstream the transcription start site within the gene promoter. The results were successfully reproduced in four separate
experiments (n= 4). Error bars represent standard deviations of four separate experiments. e Schematic illustration of the V5-tagged NM1 constructs
expressed in HEK293T cells (top panel) and their expressions as monitored on immunoblots using anti-V5 epitope antibodies as well as expressions of actin,
SNF2h and WSTF. f Chromatin profile from HEK293T cells stably expressing V5-wtNM1, V5-RK605AA NM1 or V5-ΔC NM1 shown as 2ΔCt of undigested and
MNase digested cross-linked chromatin. The position of each primer pair within the human RPL19 gene is indicated below the graph. The location
+100 bp corresponds to the coding region of the gene; the location +1 bp corresponds to the transcription start site; the location −70 bp corresponds to
a sequence upstream the transcription start site within the gene promoter. The results were successfully reproduced in four separate experiments (n= 4).
Error bars represent standard deviations of four separate experiments. An effect is detected upon expression of V5-RK605AA NM1 at −70, p= 0.01 (*), and
at −140 p= 0.008 (**). g ChIP assays and qPCR analysis on chromatin isolated from HEK293T cells stably expressing V5-wtNM1 or V5-RK605AA NM1 using
antibodies against V5, WSTF, SNF2h, actin and non-specific IgGs. qPCR analysis was performed with primers amplifying around the −70 bp region upstream
the transcription start site within the human RPL19 gene promoter. The values are presented as the percentage of the input signal for each pair. The
experiment was successfully reproduced two times (n=2). h Pol II transcription analysis performed in HEK293T cells stably expressing V5-wtNM1, V5-RK605AA
or V5-ΔC NM1 mutants. For the analysis, relative mRNA levels from the human genes RAD9A and RPL19 were monitored from polyA mRNA preparations
by RT-qPCR using GAPDH mRNA as internal control. Error bars represent the standard deviation of three independent experiments (n= 3). RAD9 mRNA
levels, pRK605AA NM1 = 5.552E-06 (****), pΔC NM1 = 0.000186 (***); RPL19 mRNA levels, pRK605AA NM1 = 0.05543 (*), pΔC NM1 = 0.000142 (***). i ChIP assays
performed on crosslinked chromatin isolated from HEK293T cells constitutively expressing V5-wt NM1, V5-RK605AA NM1 or V5-ΔC NM1 using an antibody
against the active Pol II (4H8) and non-specific IgGs. The precipitated DNA was analyzed by qPCR with primers amplifying the human RAD9A and RPL19
promoters. The bar diagrams show the relative amounts of DNA precipitated with the indicated antibodies. The values are presented as the percentage of
the input signal for each pair. Error bars represent standard deviations of three independent experiments (n= 3). Left panel (RAD9 promoter occupancy),
pRK605AA NM1 = 0.000118 (***), pΔC NM1 = 0.00032 (***); right panel (RPL19 promoter occupancy), pRK605AA NM1 = 5.826E-06 (****), pΔC NM1 = 5.288E-06 (****) bp
base pair, ChIP-Seq chromatin immunoprecipitation and deep sequencing, NM1 nuclear myosin 1c, qPCR quantitative polymerase chain reaction
Almuzzaini et al. BMC Biology  (2015) 13:35 Page 9 of 15
Fig. 6 At class II promoters NM1 maintains and preserves active epigenetic marks by direct recruitment of the HAT PCAF and the HMT Set1/Ash2.
a-d ChIP and qPCR analysis on chromatin isolated from NM1 knockdown MEFs (NM1 RNAi) and control MEFs (scrRNAi), using antibodies against
PCAF, Set1/Ash2, H3K9Ac, H3K27Ac, H3K4me3 and H3K4me1 as well as non-specific IgGs. In all cases, qPCR analysis was performed with primers
amplifying (a, c) the mouse Rpl19 gene promoter and (b, d) the mouse Rad9a gene promoter. All ChIP experiments were successfully performed
at least three times (n = 3). The values are presented as the percentage of the input signal for each primer pair. Error bars represent standard
deviations. Upon NM1 gene knockdown, significant changes were detected for PCAF, Set1/Ash2 and for the epigenetic marks H3K9Ac, H3K27ac and
H3K4me3. In panel a, pPCAF = 0.00472 (**), pSet1/Ash2 = 0.0214 (*); in panel b, pPCAF = 0.01 (**), pSet1/Ash2 = 0.0026 (***); in panel c, pH3K9ac = 0.000353 (***),
pH3K27ac = 5.93E-05 (****), pH3K4me3 = 0.000271 (***); in panel d, pH3K9ac = 8.04E-05 (****), pH3K27ac = 4.92E-05 (****), pH3K4me3 = 0.0046 (**). Significances
were obtained by Student’s t-test, two-sample equal variance. ns = non-significant ChIP-Seq chromatin immunoprecipitation and deep sequencing,
HAT histone acetyl transferase, HMT histone methyl transferase, MEFs mouse embryonic fibroblasts, NM1 nuclear myosin 1c, qPCR quantitative
polymerase chain reaction
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tion through a mechanism that facilitates loading and
maintenance of the hypophosphorylated Pol II within
class II promoters. We propose that NM1 performs this
function in concert with actin bound to the hypopho-
sphorylated Pol II [30, 31]. Indeed, actin itself and the
two actin-binding Pol II core subunits, Rpb6 and Rpb8,
efficiently interact with the promoter only in the pres-
ence of NM1. Moreover, stable expression of the
RK605AA NM1 mutant, which does not efficiently inter-
act with the chromatin and is deficient in actin-binding
activity [20, 25], impairs association of actin with the
gene promoter. We therefore suggest that there is afunctional synergy between NM1 and actin at the gene
level that is conceivably required to position the Pol II
machinery at the gene promoter (Fig. 7a), possibly min-
imizing promoter leakage.
Our present findings also underscore the importance
of the interaction between NM1 and SNF2h to start
transcription at class II promoters. Genome-wide analysis
by ChIP-Seq shows that NM1 and SNF2h co-localize at
multiple genomic locations. The overlap between NM1
and SNF2h is not complete, consistent with a more gen-
eral role of the chromatin remodeler SNF2h in the context
of other nuclear functions [35]. Interestingly, however,
NM1 silencing generally impaired SNF2h binding to the
Fig. 7 A speculative model in which NM1 coordinates the local remodeling and maintenance of active epigenetic marks for transcription
activation of class II promoters. a NM1 interacts with actin bound to Pol II via the two core subunits Rpb6 and Rpb8. b NM1 can also interact
with SNF2h, thus facilitating B-WICH assembly to promote remodeling. We speculate that the NM1-actin and NM1-SNF2h interactions may
depend on the ATPase activity of NM1 and may exclude each other. c This is followed by the establishment of H3K9ac, H3K27ac and H3K4me3
through NM1-mediated recruitment of the HAT PCAF and the HMT Set1/Ash2 that ultimately leads to transcription activation HAT histone acetyl
transferase, HMT histone methyl transferase, NM1 nuclear myosin 1c
Almuzzaini et al. BMC Biology  (2015) 13:35 Page 11 of 15chromatin at class II promoters but led to gene-specific
fluctuations in the levels of WSTF. These findings suggest
that WSTF forms a complex with NM1 and SNF2h only
at a subset of promoters. At these promoters (such as the
mouse Rpl19 and Rad9a promoters), consistent with the
finding that WSTF is required to co-precipitate NM1 and
SNF2h from nuclear fractions [25], the WSTF-bound
chromatin is likely to mark the precise location forB-WICH assembly. NM1, on the other hand, seems
to play an important role in stabilizing B-WICH to
exert its function. We found that stable expression of
the transcriptional dominant negative RK605AA NM1
mutant led to a local closing of chromatin and a drop
in the occupancy levels of SNF2h. Considering the
avid interaction between the RK605AA NM1 mutant
and SNF2h [25], during WSTF-dependent B-WICH
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SNF2h with WSTF and thus with the chromatin, and
this is a pre-condition for SNF2h to catalyze correct
repositioning of nucleosomes (Fig. 7b). It is tempting
to hypothesize that this, in turn, produces a major
impact on Pol II transcription by controlling histone
H1 dynamics [36]. We therefore propose that follow-
ing B-WICH assembly, SNF2h-mediated remodeling
opens up the chromatin to make it accessible to those
histone modifications that occur immediately after
repositioning of the nucleosomes and appear to be
dependent on NM1. Indeed, NM1 gene knockdown
led to decreased levels of epigenetic marks for active
transcription, including H3K9ac, H3K4me3 and
H3K27ac, but did not affect the levels of H3K4me1.
These changes correlate with NM1-dependent drops
of PCAF and Set1/Ash2. Therefore, it is likely that
both histone modifiers are physically recruited by
NM1to the gene promoter, conceivably when NM1
does not interact with actin [25]. In conclusion, we
propose that the active epigenetic marks H3K9ac and
H3K4me3 are under the direct control of NM1 but
require a local pre-setting of the chromatin mediated
by SNF2h in order to be fully executed and promote
transcription activation (Fig. 7c).
Conclusions
Class 1 myosins serve as divalent crosslinkers, physically
connecting and generating force between actin filaments
and cargos such as membrane lipids [37]. Our results
suggest that in the cell nucleus NM1 does not seem to
be an exception to the rule, although unconventional
modes of action are possible. In our working model, the
role of NM1 at class II promoters is dictated by its
motor activity. It is linked to a cycle of attachment and
detachment from dynamic Pol II-associated actin and
provides a physical link between Pol II and chromatin.
We speculate that the polymerase-associated actin
undergoes dynamic changes in the polymerization state
yet to be understood. The model translates into a tem-
poral framework that coordinates the functions of actin
in positioning hypophosphorylated Pol II at a specific
site within the gene promoter, with the role of SNF2h as
chromatin remodeler followed by H3K9ac, H3K4me3
and H3K27ac. This mechanism ultimately ensures that
the Pol II machinery is exposed to a local chromatin
landscape compatible with transcription activation as it
lowers the nucleosome barrier and allows for efficient
promoter clearance [38]. NM1 is enriched at the gene
promoter but it also distributes across the gene. We
therefore speculate that the above mechanism may also
be important for Pol II transcription elongation and
NM1 may synergize not only with SNF2h but with a
cohort of chromatin remodelers.Transcriptional activation is a fundamental cellular
process essential for living organisms and it is spread
across the entire genome. The association of NM1 with
a large number of class II genes therefore argues that
NM1 is a general factor involved in transcription activa-
tion. We speculate that this positive role in conjunction
with actin and with the WSTF/SNF2h complex regulates
genes that must be rapidly reprogrammed through chro-
matin de-repression in order to be activated. Nuclear
actin and components of the SNF2 members of chromatin
remodelers are important in transcriptional reprogram-
ming [39–42]. A recent study has specifically shown the
importance of SNF2h to establish gene expression pro-
grams underlying cerebellar morphogenesis and neural
maturation in mice [36]. We therefore hypothesize that as
a consequence of its motor function NM1 balls between
actin and SNF2h to regulate open chromatin states, pro-
viding a genome-wide mechanism that rapidly establishes
and preserves transcriptional programs during decisions
important for cell fate and behavior.
Methods
Cell culture and reagents
Mouse embryonic fibroblasts (MEFs), wild-type
HEK293T cells and HEK293T cells constitutively ex-
pressing the V5-tagged NM1 constructs V5-wtNM1, V5-
RK605AA NM1 or V5-ΔC NM1 were grown in DMEM
medium (Gibco, Life Technology, Carlsbad, CA, USA),
supplemented with 10 % fetal bovine serum (Gibco) and
a 1 % penicillin/streptomycin cocktail (Gibco) as previ-
ously performed [25, 26]. The antibodies against WSTF
(ab50850), SNF2h (ab3749), H3K4m1 (ab8895), H3k4me3
(ab8580), H3K9Ac (ab10812) and H3k27ac (ab4729), Set1/
Ash2 (ab70378), Rpb8 (ab104802), as well as 8WG16
(ab817) and 4H8 (ab5408) respectively targeting non-
phosphorylated and hypophosphorylated (phospho-S5)
heptapeptide repeats from the CTD of the largest Pol II
subunit were all purchased from Abcam, Cambridge,
UK. The antibodies against PCAF (sc13124) and Rpb6
(sc28711) were from Santa Cruz Biotechnology, Inc.
Dallas, TX, USA. The antibodies to actin are specific for
the β-isoform and were purchased from Sigma-Aldrich,
St. Louis, MO, USA (clone AC74). The antibody against
the V5 epitope (A190-120A) was purchased from
Bethyl, Montgomery, TX, USA Laboratories. The non-
specific rabbit IgGs (ab46540) were from Abcam. The
antibody against NM1 has previously been characterized
[15]. The anti-pan-myosin-Ic monoclonal antibody that
recognizes an epitope in the tail region of myosin Ic has
been previously characterized [43] and was provided by
Dr. W. Hofmann (University at Buffalo-SUNY). RNAi
duplexes against the target sequence GCACACGG-
CUUGGCACAGA in the mouse NM1 (NM1 RNAi) or
control scrambled versions (scrRNAi) were purchased
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applied by transfection with Lipofectamine RNAi Max
(Invitrogen, Waltham, Massachusetts, USA) at a final con-
centration of 30 nM. RNAi duplexes against human NM1
or control scrambled versions were previously described
and they were applied by transfection with Lipofectamine
RNAi Max (Invitrogen) at a final concentration of 30 nM
as previously described [25]. The HEK293T cells stably ex-
pressing V5-wt NM1, V5-RK605AA NM1 and V5-ΔC
NM1 were a kind gift of Ingrid Grummt, German Cancer
Research Center, Heidelberg, Germany [20].
Quantitative RT-qPCR
MEFs transfected with NM1 RNAi duplexes or control
scrRNAi duplexes were grown in 10 cm dishes for 24 h
at 37 °C. Total RNA was extracted with the TRI reagent
as specified by the manufacturer’s instruction manual
(Sigma). For analysis of transcripts, polyA mRNA was
isolated from NM1-silenced or control cells using the
Oligotex mRNA Mini Kit according to the manufac-
turer’s protocol (Qiagen, Venlo, Limburg, Netherlands)
and treated with DNase1. cDNA was then synthesized
using Superscript II reverse transcriptase (Invitrogen)
using oligo dT primers according to the manufacturer’s
instructions. The concentration of cDNA was determined
by nanodrop. Semi-quantitative RT-qPCR was performed
using the cDNA templates prepared from MEFs treated
with control scrRNAi duplexes or from MEFs treated with
NM1 RNAi duplexes, a Power SYBR Green PCR kit (Life
Technology, Carlsbad, CA, USA), specific primers ampli-
fying the mouse class II genes Rplp0, Rpl13a, Rpl19, Junb,
Rad9a, Wtap, Ddx46 as well as Bad and the human
class II genes RAD9A and RPL19 (see Additional file 8:
Table S3) and a 7300 Real Time PCR System (Applied
Biosystems, Waltham, Massachusetts, USA). For all primers
the annealing temperature was 60 °C. All samples were run
in triplicate. Relative changes in RNA levels were calculated
against the reference β-actin gene using the delta-delta Ct
method as previously described [25].
Western blotting
Cells were lysed in RIPA buffer (50 mM Tris‐HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 % NP‐40, 0.5 % sodium
deoxycholate, 0.1 % SDS) supplemented with protease in-
hibitors (cOmplete cocktail, Roche, Basel, Switzerland).
For denaturation, protein extracts were incubated in
Laemmli buffer at 95 °C for 10 min, separated by SDS–
PAGE under reducing conditions and transferred to poly-
vinylidene difluoride (PVDF) membranes (Millipore,
Billerica, Massachusetts, USA) by semidry blotting (Biorad,
Hercules, CA, USA). Primary antibodies and dilutions used
were NM1 (1:1000), β-actin (Sigma, 1:50000), WSTF
(Abcam, 1:2000), SNF2h (Abcam, 1:500), PCAF (Abcam,
1:500), Set1/Ash2 (Abcam, 1:500). Immunoreactive bandswere visualized by chemiluminescence (Amersham, GE
Healthcare Life Sciences, Pittsburgh, USA).
High-resolution MNase assay
These experiments were essentially performed as de-
scribed [25, 34]. Briefly, HEK293T cells subjected to
control or NM1 gene knockdown by RNAi [25], and
HEK293T stably expressing V5-wtNM1, V5-RK605AA
NM1 or V5-ΔC NM1 were crosslinked with 1 % formal-
dehyde for 20 min. Chromatin was prepared as for ChIP
(see below), but washed with Buffer D containing 25 %
glycerol, 5 mM magnesium acetate, 50 mM Tris
(pH 8.0), 0.1 mM EDTA, 5 mM DTT. Before digestion
with MNase the chromatin was lightly sonicated in
MNase buffer (60 mM KCl, 15 mM NaCl, 15 mM Tris
at pH 7.4, 0.5 mM DTT, 0.25 M sucrose, 1.0 mM
CaCl2), 8 times for 30 s. The equivalent of 0.46 × 106
cells was used in each reaction, and the level of DNA
was first adjusted to be in the same range in the samples
from all different treatments. Several MNase concentra-
tions were used such that the reaction occurred in the
linear range of digestion. Two samples from each treat-
ment were used for the calculations: 10 U MNase and
one concentration between 10 U and 20 U MNase. The
reactions were performed at 37 °C for 30 min and then
stopped by adding 12.5 mM EDTA/0.5 % SDS. After
three hours of proteinase K treatment, the cross-linking
was reversed at 65 °C for five hours. DNA was extracted
[25] and the digest was evaluated by qPCR with primers
amplifying around the transcription start site of the
mouse Rpl19 gene (primers available upon request) and
human RPL19 gene (for the mouse primers sequences
see Additional file 9: Table S4), giving a product of ap-
proximately 100 bp. The results were analyzed by calcu-
lating ΔCt between the reactions performed with and
without MNase. The values are presented as 2ΔCt.
Chromatin from cells transfected with control siRNA
oligonucleotides and chromatin from untransfected
cells gave the same MNase digestion pattern. P-values
(significances) were obtained by Student’s t-test as pre-
viously described [25].
ChIP and qPCR analysis
ChIP on growing MEFs was performed as previously de-
scribed [25]. Briefly, formaldehyde cross-linked chroma-
tin was obtained from in vivo cross-linked MEFs and
subjected to immunoprecipitations with antibodies to
Pol II (8WG16 and 4H8), Rbp6, Rbp8, NM1, actin, WSTF,
SNF2h, H3K9Ac, H3K27Ac, H3K4me1, H3K4me3, PCAF,
Set1/Ash2, HDAC1 and non-specific rabbit IgGs. DNA-
protein complexes were analyzed by qPCR with specific
primers amplifying class II promoters (see Additional
file 10: Table S5 for the primers sequences). qPCR was
performed using SYBR-green from Applied Biosystems
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concentration was 2.5 mM and the samples analyzed by
qPCR (7300 Real Time PCR System, Applied Biosystem).
The PCR conditions were: hold 50 °C for 2 min, 95 °C for
10 min, 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s. The
results were analyzed using an average of Ct of no anti-
body as background. The 2ΔCt of each sample in
triplicate was related to the 2ΔCt of the input sample.
P-values (significances) were obtained by Student’s t-test
as previously described [25].
ChIP assays were also performed on formaldehyde
crosslinked chromatin isolated from wild-type HEK293T
and HEK293T cells expressing V5-wtNM1, V5-RK605AA
NM1 and V5-ΔC NM1 mutants using antibodies against
the V5 epitope, NM1 and histone H3 as well as non-
specific rabbit IgGs. Precipitated chromatin was analyzed
by PCR with primers to the EP300 gene promoter and
exonic sequences and the PCR products visualized by
agarose gel electrophoresis. For the primers sequences
see [44].ChIP-Seq, sequencing, data alignment and analysis
For ChIP-Seq analysis, crosslinked chromatin from
MEFs was subjected to immunoprecipitation with anti-
bodies to NM1. A total of 5 ng of precipitated DNA was
used to prepare sequencing libraries at the Bejing
Genome Institute (Hong Kong) using the Illumina HiSeq
2000 platform. The analysis procedure involved the use
of the SOAP2 program to map the reads to the mouse
reference genome. Sequences with more than two mis-
matches were discarded from further analysis. The
resulting individual sequences were remapped back to
the annotated UCSC MM9 reference sequence which al-
lows for the identification of peaks corresponding to the
levels of association of the ChIP target with those loci.
The ChIP-Seq data sets are available for download in the
Gene Expression Omnibus (GEO) database (accession
number GSE66542). The ChIPseek program was used to
analyze the genomic distribution of NM1 across coding
and non-coding elements and around the transcription
start site (TSS) [45]. For this all genomic locations with
a score of 10 sequences per 50 bp or above were se-
lected. The ChIPseek program was also used for pairwise
comparison of the NM1 ChIPSeq data with the SNF2h
ChIPSeq data [3].Additional files
Additional file 1: Figure S1. Gene Onthology (GO) enrichment analysis
of peak-related genes. The horizontal axis is labelled with GO items
(biological processes, cellular components and molecular functions). The
left vertical axis indicates the proportion of genes involved and the right
vertical axis marks the exact number of genes.Additional file 2: Table S1. Lists the NM1 occupancy at Pol II genes
promoters selected from the ChIP Seq data.
Additional file 3: Figure S2. Selected ChIP-Seq profiles showing
occupancies of NM1 at selected class II genes. The profiles show peaks of
NM1 occupancy at the promoters of mouse genes encoding the
proteasome (prosome, macropain) 26S subunit non-ATPase 3 (Psmd3),
the RNA helicase DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 (Ddx46)
and the pre-mRNA-splicing regulator Wtap.
Additional file 4: Figure S3. Validation of ChIP-Seq data by ChIP and
qPCR analysis. For this we used selected class II promoters of mouse genes
encoding the ribosomal proteins Rplp0 and Rpl19, the transcription factor
(JunB), the Holliday Junction recognition protein (Hjurp), the checkpoint
clamp complex protein (Rad9a), the BCL2-associated agonist of cell death
Bad, the proteasome (prosome, macropain) 26S subunit non-ATPase 3
(Psmd3), the RNA helicase DEAD (Asp-Glu-Ala-Asp) box polypeptide 46
(Ddx46) and the pre-mRNA-splicing regulator Wtap. All ChIP experiments
were successfully reproduced three times (n = 3). The values are presented
as the percentage of the input signal for each primer pair. Error bars
represent standard deviations.
Additional file 5: Table S2. Comprises the list of genes where NM1
and SNF2h co-localize.
Additional file 6: Figure S4. NM1 controls the levels of SNF2h at class
II promoters. (A-C) ChIP and qPCR analysis on chromatin isolated from
NM1 knockdown cells (NM1 RNAi) and control cells (scrRNAi), using
antibodies against NM1, WSTF and SNF2h. The qPCR analysis was
performed with primers amplifying the promoters of the mouse genes
encoding (A) the transcription factor JunB gene (Junb), (B) the Holliday
junction recognition protein gene (Hjurp), (C) the apoptotic factor
BCL2-associated agonist of cell death gene (Bad) and (D) the ribosomal
protein Rpl13a. In all cases, the values are presented as the percentage of
the input signal for each primer pair. All ChIP experiments were performed
at least three times (n = 3). Error bars represent standard deviations.
Significances (p-values) were obtained by Student’s T-test, two-sample
equal variance. Panel A, pWSTF = 0.037 (*), pSNF2h = 0.0042 (**); panel B,
pSNF2h = 0.0025 (**); panel C, pWSTF = 0.0040 (**), pSNF2h = 0.0017 (**);
panel D, pSNF2h = 0.0054 (**). ns = non-significant.
Additional file 7: Figure S5. A functional NM1 is required for interaction
with the chromatin. (A) Schematic representation of V5-tagged wt and
mutated NM1 constructs stably expressed in HEK293T cells. (B) Schematic
representation of the EP300 gene used as model gene for the ChIP assays.
The numbers at the bottom of the gene structure indicate the positions of
each primer used in the ChIP experiments. Steady state expressions of
V5-tagged wt and mutated NM1 constructs were monitored on immunoblots
for V5 and actin antibodies as loading control. (C) ChIP analysis on chromatin
isolated from wild type HEK293T cells or HEK293T cells expressing V5-wtNM1,
V5 RK609AA NM1, V5-ΔC NM1 and V5-ΔIQ NM1, using an antibody against
the V5 epitope, antibodies against histone H3 and non-specific rabbit IgGs. In
all cases, the ChIP was analyzed by PCR, agarose gel electrophoresis and
ethidium bromide staining. Bottom parts, densitometric quantification of
relative occupancies. Bar diagrams represent values calculated from analysis
of exon 3, exon 6 and exon 31 in duplicates. All values are normalized
against the signals obtained with the anti-V5 antibody targeting the V5-wt
NM1 construct.
Additional file 8: Table S3. Listing primers used in the RTqPCR analysis
of mRNA levels upon NM1 gene knockdown.
Additional file 9: Table S4. Listing primers targeting the human
RPLP19 gene promoter, used in the MNase/qPCR assay.
Additional file 10: Table S5. Listing primers used in the ChIP/qPCR
analyses.
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